Sept 23 (Reuters) – Novo Nordisk is open to the idea of upgrading its New York listing as part of efforts to raise the Danish weight-loss drugmaker's profile in the country, its chief executive told
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
By Helen Clark and Siyi Liu PERTH/SINGAPORE, Sept 23 (Reuters) - Oil prices extended declines…
MUMBAI, Sept 23 (Reuters) - STOCKS: The benchmark BSE Sensex was up 0.16% at 74644,…
VIDEO SHOWS: HIGHLIGHTS OF THE MLB GAME BETWEEN THE TAMPA BAY RAYS AND THE NEW…
By Ross Kerber Sept 22 (Reuters) - Microsoft will consider shareholder proposals at its annual…
By Dharamraj Dhutia MUMBAI, Sept 23 (Reuters) - India's National Bank for Financing Infrastructure and…
Here are some factors that may affect Middle East stock markets on Wednesday. Reuters has…